List of Skelaxin drug patents

Skelaxin is owned by King Pharms.

Skelaxin contains Metaxalone.

Skelaxin has a total of 1 drug patent out of which 0 drug patents have expired.

Skelaxin was authorised for market use on 30 August, 2002.

Skelaxin is available in tablet;oral dosage forms.

Skelaxin can be used as treatment of musculoskeletal conditions.

The generics of Skelaxin are possible to be released after 06 February, 2026.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7122566 KING PHARMS Metaxalone products, method of manufacture, and method of use
Feb, 2026

(3 years from now)

Drugs and Companies using METAXALONE ingredient

Market Authorisation Date: 30 August, 2002

Treatment: Treatment of musculoskeletal conditions

Dosage: TABLET;ORAL

How can I launch a generic of SKELAXIN before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in